Radial Shock Wave Therapy for secondary lymphedema: A pilot study.

Radial Shock Wave Therapy for secondary lymphedema: A pilot study. - Radial Shock Wave Therapy for secondary lymphedema

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002582

Enrollment

Registered

2009-10-05

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

secondary lymphedema

Interventions

Radial Shock Wave Therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. secondary lymphedema 2. ISL stage II, III 3. Lymphedema of extremities

Exclusion criteria

Exclusion criteria: 1. primary lymphedema 2. lymphedema caused by direct invasion of cancer cells to the lymphatic system 3. venous edema due to thromboembolism 4. generalized edema 5. history of deep venous thrombosis 6. severe heart failure 7. severe respiratory failure 8. acute inflammation (generalized, local) 9. any other causes which can disturb data aquisition (decision should be made by investigators)

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
extremity volume, quality of life, sepecific symptoms related to lymphedema	—

Countries

Japan

Contacts

Public ContactKotaro Suehiro

Yamaguchi University Hospital Medical Bioregulation Department of Organ Regulatory Surgery

ksuehiro-circ@umin.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026